Headline

The latest stories from AHA Today.

Applications are now open for the AHA Rural Hospital Excellence in Innovation Award, which recognizes and shares the accomplishments of rural hospitals that demonstrate responsiveness, innovation and excellence in developing, implementing and sustaining programs and services.
The Food and Drug Administration April 28 announced its plan to advance the implementation of real-time clinical trials, which invite participants to supply reports and data to the agency during the approved clinical trials rather than at completion.
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.
The Food and Drug Administration has identified a nationwide recall.
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to discounted drug prices unless they comply with new data submission requirements.
The Utah measles outbreak has increased to 607 cases, the state’s Department of Health and Human Services reported April 24.
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreement by a drug manufacturer with the Trump administration, and it ensures Regeneron’s prices are in line with the lowest…
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18 executive order calling to speed up access to treatments for serious mental illness.
The AHA April 24 urged the Sequoia Project to delay implementation of the Trusted Exchange Framework and Common Agreement Individual Access Services Exchange Purpose Standard Operating Procedures version 3.0 until key legal and regulatory issues are resolved.